We recently published a list of Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks. In this article, we are going to ...
Oppenheimer updated its outlook on Tarsus Pharmaceuticals (NASDAQ:TARS), a $1.8 billion market cap biotechnology company, ...
Oppenheimer analyst Francois Brisebois raised the firm’s price target on Tarsus Pharmaceuticals (TARS) to $72 from $65 and keeps an Outperform ...
Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have been assigned an average rating of “Buy” from the ...
Cory Jubinville, PhD, an analyst from LifeSci Capital, maintained the Buy rating on Tarsus Pharmaceuticals (TARS – Research Report). The ...
Oppenheimer分析师Francois Brisebois解释了上调目标价的理由。评论重点关注了Tarsus Pharmaceuticals的产品XDEMVY的令人印象深刻的销售数据,特别强调了其在治疗眼部玫瑰痤疮方面的潜力。该公司展现了显著的增长,InvestingPro数据显示,过去十二个月的收入增长率高达802%。
The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.
This feature is currently unavailable; we are sorry for the inconvenience to you. Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets ...
The Anchor Bay girls basketball team is on a roll – thanks to 25 points by Julia Tkaczyk, the Tars were able to take out ...
BlockBeats 消息,1 月 15 日,据 WEEX 交易平台公告,该平台已上线第 61 期 WE-Launch 项目 TARS AI (TAI),用户于 1 月 19 日 22:00 UTC+8 之前投入 WXT 和/或 TAI,即可按有效投入占比瓜分 16,000 TAI 代币。WXT 奖池占比 70%,TAI 奖池占比 30%。投入的 WXT 和 TAI 不消耗,可同时参与其他项目或交 ...